Cure My Disease

Don't miss your cure!

 Log in / Sign up

Muscle loss may predict who struggles after cancer surgery

NCT ID NCT07817758

Knowledge-focused Sponsor: Van Training and Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 14, 2026 · Last updated Sep 15, 2026 · Updated 1 time

Summary

Researchers are studying whether older adults with gastrointestinal cancer who have low muscle mass and strength before surgery recover worse afterward. The study enrolls about 100 people aged 60 and older who are scheduled for elective cancer surgery. Before their operation, participants complete muscle strength, muscle mass, and physical performance assessments, plus a questionnaire and calf measurement. The team then tracks complications, hospital stay length, and deaths at 30 and 90 days after surgery to see how these connect to preoperative muscle loss.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If muscle loss before surgery turns out to predict worse outcomes, doctors could use simple strength and muscle measurements to flag high-risk older patients and plan extra support around their operation.
What could go wrong
This is an observational study of 100 people at one hospital, so it can show a link between muscle loss and outcomes but cannot prove cause and effect. Findings may not apply to other hospitals, cancer types, or patients who differ from those enrolled.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients aged 60 years or older with gastrointestinal system cancer who are scheduled to undergo elective surgery at the General Surgery Clinic of Van Training and Research Hospital.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 60 years or older * Diagnosis of gastrointestinal system cancer * Scheduled to undergo elective surgical treatment * Considered operable based on routine clinical evaluation * Ability to complete the preoperative sarcopenia assessments * Provision of written informed consent Exclusion Criteria: * Age younger than 60 years * Undergoing emergency surgery * Inability to complete the required preoperative sarcopenia assessment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gastrointestinal cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

digestive system cancer digestive system neoplasm Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gastrointestinal neoplasms Sarcopenia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Van Education and Research Hospital

    RECRUITING

    Van, Van, 65300, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.